Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
URGN:NASDAQ
Urogen Pharma Ltd
$28.78
-3.03%
(-0.90) 1D
$28.78
0.00% (0.00)
After hours
Closed: May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
$29.26
High
$29.59
Low
$28.26
Mkt. cap
1.40B
Avg. vol.
923.19K
Volume
944.07K
52-wk high
$32.37
52-wk low
$3.42
EPS
-$2.75
Beta
1.58
Shares outstanding
48.72M
No. of employees
298
News stories
From sources across the web
About Urogen Pharma Ltd
CEO-
Employees298
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteurogen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
24.22M
27.48M
37.84M
50.96M
Cost of goods sold
3.55M
3.28M
3.29M
4.14M
Cost of revenue
3.55M
3.28M
3.29M
4.14M
Research and development expenses
18.91M
14.01M
14.31M
15.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.20M
37.58M
39.35M
51.49M
Operating expense
62.11M
51.59M
53.66M
67.08M
Total operating expenses
65.66M
54.87M
56.95M
71.22M
Operating income
-41.45M
-27.39M
-19.12M
-20.26M
Other non operating income
-5.02M
-4.82M
-4.66M
-4.83M
EBT including unusual items
-48.92M
-34.40M
-26.64M
-28.35M
EBT excluding unusual items
-48.92M
-34.40M
-26.64M
-28.35M
Income tax expense
1.02M
-1.05M
-275.00K
-4.77M
Effective tax rate
-2.07%
3.06%
1.03%
16.83%
Other operating expenses
-
-
-
-
Net income
-49.94M
-33.35M
-26.36M
-23.57M
Net profit margin
-206.24%
-121.34%
-69.68%
-46.26%
Earnings per share
-1.05
-0.69
-0.53
-0.47
Interest and investment income
1.68M
1.18M
908.00K
931.00K
Interest expense
-4.13M
-3.37M
-3.77M
-4.18M
Net interest expenses
-2.46M
-2.20M
-2.86M
-3.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.37M
-26.40M
-19.04M
-20.19M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer